Rapid manufacturing of vaccines for pandemic response & personalized cancer: parallels to leverage for common pathways to expedite clinical development?

Vaccine Insights 2023; 2(4), 73–76

DOI: 10.18609/vac/2023.013

Published: 15 April 2023
Antu K. Dey

“...the paradigm shifts required to substantially condense timelines could come from the field of neoantigen based personalized cancer vaccines.”